WHITEWING LABS INC
10QSB, EX-27, 2000-08-11
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: WHITEWING LABS INC, 10QSB, 2000-08-11
Next: LASALLE RE HOLDINGS LTD, 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE>   5
<LEGEND>
Exhibit 27  Financial Data Schedule

This schedule contains summary financial information extracted from the
Company's unaudited financial statements at June 30, 1999 and 2000, and is
qualified in its entirety by reference to such financial statements.



<S>                                           <C>                 <C>
<PERIOD-TYPE>                                 6-MOS               6-MOS
<FISCAL-YEAR-END>                             DEC-31-1998         DEC-31-1999
<PERIOD-END>                                  JUN-20-1999         JUN-30-2000
<CASH>                                            102,782              64,234
<SECURITIES>                                    1,066,065             748,232
<RECEIVABLES>                                      31,900              11,468
<ALLOWANCES>                                            0                   0
<INVENTORY>                                        84,970              76,287
<CURRENT-ASSETS>                                1,575,690           1,016,455
<PP&E>                                            161,379             166,562
<DEPRECIATION>                                    108,058             138,431
<TOTAL-ASSETS>                                  1,678,309           1,098,578
<CURRENT-LIABILITIES>                              76,892              27,865
<BONDS>                                                 0                   0
                                   0                   0
                                             0                   0
<COMMON>                                            2,925               2,925
<OTHER-SE>                                      6,248,746           6,248,746
<TOTAL-LIABILITY-AND-EQUITY>                    1,678,309           1,098,578
<SALES>                                           962,175             462,499
<TOTAL-REVENUES>                                  962,175             462,499
<CGS>                                             151,965              84,462
<TOTAL-COSTS>                                   1,001,080             341,999
<OTHER-EXPENSES>                                  314,702             284,680
<LOSS-PROVISION>                                        0                   0
<INTEREST-EXPENSE>                                      0                   0
<INCOME-PRETAX>                                  (315,428)           (131,892)
<INCOME-TAX>                                            0                   0
<INCOME-CONTINUING>                              (315,428)           (131,892)
<DISCONTINUED>                                          0                   0
<EXTRAORDINARY>                                         0                   0
<CHANGES>                                               0                   0
<NET-INCOME>                                     (315,428)           (131,892)
<EPS-BASIC>                                       (0.11)              (0.05)
<EPS-DILUTED>                                       (0.11)              (0.05)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission